$EXPO
EXPONENT INC

2017 Q3 Form 10-Q Financial Statement

#000114420417056191 Filed on November 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $87.56M $77.01M $77.61M
YoY Change 12.81% -2.51% -2.82%
Cost Of Revenue $5.200M $4.300M $4.000M
YoY Change 30.0% -4.44% -13.04%
Gross Profit $82.40M $72.80M $73.30M
YoY Change 12.41% -2.28% -2.66%
Gross Profit Margin 94.11% 94.53% 94.44%
Selling, General & Admin $55.60M $50.60M $51.20M
YoY Change 8.59% 8.12% 2.61%
% of Gross Profit 67.48% 69.51% 69.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.600M $1.600M $1.500M
YoY Change 6.67% 23.08% 15.38%
% of Gross Profit 1.94% 2.2% 2.05%
Operating Expenses $68.25M $57.80M $62.02M
YoY Change 10.05% -0.47% 1.4%
Operating Profit $19.31M $14.95M $15.60M
YoY Change 23.79% -28.55% -16.63%
Interest Expense $400.0K $200.0K $200.0K
YoY Change 100.0%
% of Operating Profit 2.07% 1.34% 1.28%
Other Income/Expense, Net $2.725M $1.600M $2.325M
YoY Change 17.2% -174.49% 296.08%
Pretax Income $22.03M $16.79M $17.92M
YoY Change 22.94% -10.56% -7.11%
Income Tax $7.387M $6.400M $6.631M
% Of Pretax Income 33.53% 38.12% 37.0%
Net Earnings $14.64M $10.39M $11.29M
YoY Change 29.71% -11.36% -3.49%
Net Earnings / Revenue 16.72% 13.49% 14.55%
Basic Earnings Per Share $0.28 $0.40 $0.43
Diluted Earnings Per Share $0.27 $0.39 $0.42
COMMON SHARES
Basic Shares Outstanding 52.74M 26.26M shares 26.55M shares
Diluted Shares Outstanding 53.93M 26.96M shares 27.19M shares

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $165.6M $173.7M $162.1M
YoY Change 2.16% 14.81% 8.14%
Cash & Equivalents $89.81M $115.0M $98.43M
Short-Term Investments $75.80M $58.80M $48.50M
Other Short-Term Assets $10.70M $12.90M $18.20M
YoY Change -41.21% -46.25% -29.18%
Inventory
Prepaid Expenses
Receivables $124.8M $87.41M $94.29M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $301.1M $274.0M $257.3M
YoY Change 17.01% 1.69% -4.38%
LONG-TERM ASSETS
Property, Plant & Equipment $35.18M $36.71M $37.46M
YoY Change -6.08% 24.86% 36.21%
Goodwill $8.607M $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.515M $1.064M $929.0K
YoY Change 63.08% -98.27% -98.52%
Total Long-Term Assets $134.6M $129.7M $128.1M
YoY Change 5.03% 30.35% 29.4%
TOTAL ASSETS
Total Short-Term Assets $301.1M $274.0M $257.3M
Total Long-Term Assets $134.6M $129.7M $128.1M
Total Assets $435.6M $403.7M $385.4M
YoY Change 13.03% 9.42% 4.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.80M $3.193M $8.700M
YoY Change 58.62% -64.12% -10.31%
Accrued Expenses $59.70M $6.880M $47.50M
YoY Change 25.68% -87.42% -2.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $81.30M $80.24M $69.17M
YoY Change 17.55% 15.28% 7.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $54.30M $2.005M $2.102M
YoY Change 2483.25% -95.29% -95.22%
Total Long-Term Liabilities $54.30M $2.005M $2.102M
YoY Change 2483.25% -95.29% -95.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.30M $80.24M $69.17M
Total Long-Term Liabilities $54.30M $2.005M $2.102M
Total Liabilities $135.6M $130.4M $118.6M
YoY Change 14.34% 16.22% 9.3%
SHAREHOLDERS EQUITY
Retained Earnings $313.3M $291.2M $285.6M
YoY Change 9.68% 11.7%
Common Stock $208.6M $194.7M $193.1M
YoY Change 8.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $219.8M $209.4M $209.5M
YoY Change 4.9% 23.05%
Treasury Stock Shares 7.043M shares 7.256M shares 7.261M shares
Shareholders Equity $300.1M $273.3M $266.8M
YoY Change
Total Liabilities & Shareholders Equity $435.6M $403.7M $385.4M
YoY Change 13.03% 9.42% 4.71%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income $14.64M $10.39M $11.29M
YoY Change 29.71% -11.36% -3.49%
Depreciation, Depletion And Amortization $1.600M $1.600M $1.500M
YoY Change 6.67% 23.08% 15.38%
Cash From Operating Activities $9.800M $29.70M $14.20M
YoY Change -30.99% 52.31% 8.4%
INVESTING ACTIVITIES
Capital Expenditures $828.0K -$1.300M $9.681M
YoY Change -91.45% -149.22% 790.62%
Acquisitions
YoY Change
Other Investing Activities -$4.000M -$7.000M $8.000M
YoY Change -150.0% -22.22% 142.42%
Cash From Investing Activities -$4.900M -$8.300M $6.100M
YoY Change -180.33% -28.45% 190.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.700M -4.400M -5.000M
YoY Change 14.0% -71.05% -29.58%
NET CHANGE
Cash From Operating Activities 9.800M 29.70M 14.20M
Cash From Investing Activities -4.900M -8.300M 6.100M
Cash From Financing Activities -5.700M -4.400M -5.000M
Net Change In Cash -800.0K 17.00M 15.30M
YoY Change -105.23% -332.88% 88.89%
FREE CASH FLOW
Cash From Operating Activities $9.800M $29.70M $14.20M
Capital Expenditures $828.0K -$1.300M $9.681M
Free Cash Flow $8.972M $31.00M $4.519M
YoY Change 98.54% 83.88% -62.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114967000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194632000 USD
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
219754000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-129000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87409000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-146000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
301086000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35180000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
313277000 USD
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
209436000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
300076000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80236000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7624000 USD
CY2017Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
46678000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
130398000 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10073000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12913000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62539000 USD
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
42574000 USD
CY2016Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
46503000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2980000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2005000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1654000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1515000 USD
CY2017Q3 us-gaap Assets
Assets
435640000 USD
CY2016Q4 us-gaap Assets
Assets
403744000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
435640000 USD
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74160000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208583000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
291243000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
19305000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15595000 USD
CY2017Q3 us-gaap Investment Income Net
InvestmentIncomeNet
372000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6631000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22030000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17920000 USD
CY2017Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
5196000 USD
CY2016Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
3452000 USD
CY2017Q3 us-gaap Revenues
Revenues
87555000 USD
CY2016Q3 us-gaap Revenues
Revenues
77612000 USD
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
51493000 USD
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
47797000 USD
CY2017Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7500000 USD
CY2016Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7020000 USD
CY2017Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
5196000 USD
CY2016Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
3452000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4061000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3748000 USD
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
179000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2353000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2146000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7387000 USD
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
58755000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
62017000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2725000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
68250000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2325000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15239000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15112000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
273346000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
246946000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
226444000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
12571000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
11619000 USD
us-gaap Revenues
Revenues
259517000 USD
us-gaap Revenues
Revenues
238063000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
157447000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
146854000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
21966000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
21221000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
12571000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
11619000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13277000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11407000 USD
us-gaap Net Income Loss
NetIncomeLoss
45010000 USD
us-gaap Net Income Loss
NetIncomeLoss
37092000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26362000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26563000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26976000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27234000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.63
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.54
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16778000 USD
us-gaap Operating Expenses
OperatingExpenses
205261000 USD
us-gaap Operating Expenses
OperatingExpenses
191101000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7532000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5369000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11084000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1046000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-696000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46073000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36461000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4762000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4509000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-7000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-314000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-330000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1657000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1688000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12728000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10659000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-421000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
61788000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52331000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1284000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26964000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37234000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20351000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19113000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9520000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7685000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8431000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24456000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1733000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1499000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
16419000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
14174000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32637000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44816000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
866000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-631000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-25158000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27326000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125751000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98425000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
20997000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
36000000 USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5374000 USD
CY2017Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16222000 USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4628000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4675000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4659000 USD
CY2016Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4607000 USD
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18569000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5265000 USD
CY2017Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
131826000 USD
CY2017Q3 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
56479000 USD
CY2017Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
56479000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21918000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
128940000 USD
CY2016Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
53617000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
53617000 USD
CY2017Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
165806000 USD
CY2017Q3 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2017Q3 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
215000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
173967000 USD
CY2016Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2016Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
245000 USD
CY2016Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
173722000 USD
CY2017Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
40000000 USD
CY2017Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
35997000 USD
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
75997000 USD
CY2017Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
39919000 USD
CY2017Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
35863000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
139182 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8431000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
491312 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
24456000 USD
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
48876000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5667000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5791000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17208000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
13375000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6910000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6334000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
162000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
739000 USD
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3847000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3417000 USD
CY2017Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
828000 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9681000 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1567000 USD
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1582000 USD
CY2017Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2063000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3126000 USD
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7043000 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7256000 shares
CY2017Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5424000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" align="justify"></div> <div style="CLEAR:both;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Use of Estimates.</font></strong> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y

Files In Submission

Name View Source Status
0001144204-17-056191-index-headers.html Edgar Link pending
0001144204-17-056191-index.html Edgar Link pending
0001144204-17-056191.txt Edgar Link pending
0001144204-17-056191-xbrl.zip Edgar Link pending
expo-20170929.xml Edgar Link completed
expo-20170929.xsd Edgar Link pending
expo-20170929_cal.xml Edgar Link unprocessable
expo-20170929_def.xml Edgar Link unprocessable
expo-20170929_lab.xml Edgar Link unprocessable
expo-20170929_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv477472_10q.htm Edgar Link pending
tv477472_ex31-1.htm Edgar Link pending
tv477472_ex31-2.htm Edgar Link pending
tv477472_ex32-1.htm Edgar Link pending
tv477472_ex32-2.htm Edgar Link pending